Pediatrics in Minnesota

Mozarc Medical is a healthcare technology company dedicated to improving kidney health, launched in April 2023 as a spinoff leveraging expertise from Medtronic's former Renal Care Solutions business. The company offers a comprehensive portfolio of kidney health solutions including hemodialysis catheters, peritoneal dialysis catheters, safety fistula cannulas, and specialized pediatric dialysis systems. Mozarc Medical emphasizes reducing complications and enhancing patient access to care, particularly for in-home dialysis environments. The company provides clinical support, education, and training resources to healthcare providers and patients, focusing on holistic kidney care solutions spanning vascular access through treatment delivery. Led by CEO Ven Manda with a global workforce, Mozarc Medical serves nephrology practices, dialysis centers, and home care programs treating chronic kidney disease, end-stage renal disease, and acute kidney injury patients.

Preceptis Medical Inc. manufactures the Hummingbird Tympanostomy Tube System (TTS), an FDA-cleared medical device that enables in-office pediatric ear tube placement without general anesthesia. The system is designed for ENT surgeons to perform tympanostomy tube insertion in an office setting, addressing the approximately 1 million pediatric ear tube procedures performed annually in the United States. The Hummingbird procedure eliminates the need for operating room facilities, general anesthesia, pre-operative testing, and post-operative recovery restrictions. Clinical benefits include immediate return to normal activities, completion in minutes, and up to 65% cost savings compared to traditional OR-based surgical approaches. The device is particularly valuable for pediatric patients with recurrent otitis media, as it restores proper middle ear ventilation and reduces fluid buildup. Preceptis Medical markets the Hummingbird to ENT physicians and pediatric families, providing physician education resources, patient support materials, and a locator service to connect patients with trained providers. The company maintains FDA 510(k) clearance and appears to operate a network of participating ENT practices offering the procedure.

The Fresnel Prism and Lens Company is an international supplier of specialty eye care products for vision practitioners and patients. Founded in 1987, the company specializes in press-on prisms and lenses used to diagnose and treat strabismus, amblyopia (lazy eye), diplopia, and other vision disorders. Primary product lines include 3M Press-On Optics (prisms and lenses), MYI Occlusion Eye Patches, Trial Lens Sets, Bangerter Foil Bar, and Prism Adapter. The company manufactures MYI eye patches in Minnesota using US-made medical adhesive and opaque occlusion layers designed to improve patient compliance, particularly in pediatric amblyopia treatment. Products are distributed globally to eye care professionals including optometrists and ophthalmologists. The company emphasizes American manufacturing, quality control, and innovative design to address clinical and patient needs in vision correction and occlusion therapy.

EarliPoint Health is a healthcare technology company specializing in FDA-cleared eye-tracking diagnostic systems for early autism spectrum disorder (ASD) detection and assessment in children ages 16 months through 95 months (7–8 years). The EarliPoint System is a portable, tablet-based device that measures visual attention biomarkers through proprietary algorithms to provide objective, quantifiable data supporting qualified clinicians in ASD diagnosis and treatment progress monitoring. The system captures eye-gaze patterns while children watch video scenes featuring social interactions, analyzing three clinically aligned indices: language, cognition, and social engagement. The company's technology is grounded in decades of developmental research, with clinical validation from large-scale, double-blind studies published in the Journal of the American Medical Association (JAMA) in collaboration with Yale University and Emory University. FDA clearance was obtained via 510(k) submission, confirming substantial equivalence and safety standards. EarliPoint Health addresses critical gaps in early autism diagnosis—the average age of diagnosis in the U.S. exceeds 4 years, well past optimal intervention windows. The system is designed for clinical use in pediatric practices, behavioral health centers, child neurology clinics, and primary care facilities. Administration requires trained staff; interpretation requires qualified clinicians. Results are delivered same-day as detailed diagnostic or progress-tracking reports. The company operates an EarliPoint Network of partner clinics and research institutions including Drexel University Autism Institute, Cincinnati Children's Hospital, University of Nebraska Medical Center, and Easterseals Florida, expanding access across rural and underserved communities.

McKie Splints designs and manufactures therapeutic splinting devices specializing in the thumb, wrist, and hand. The company offers neoprene thumb splints, supination straps, and custom wrist-hand orthotics with biomechanically aligned designs to assist weaker muscles during grasp and reach activities. Products are available in six colors and in sizes for infants, children, teenagers, and adults. McKie Splints are recommended by occupational therapists, physical therapists, and wrist/hand orthotists nationally and internationally. The company serves patients with conditions including arthritis, cerebral palsy, hemiplegia, multiple sclerosis, stroke, trigger thumb, tendonitis, and various neurological disorders. McKie Splints also offers splinting webinars and product consultations for OT & PT teams and healthcare organizations.

YourSteps Health develops a cloud-based pediatric rehabilitation platform designed to extend therapy beyond clinic walls. The platform integrates physical therapy, occupational therapy, and speech-language pathology into a unified digital health solution for children ages 0–18. The platform comprises two main components: a therapist portal for care coordination, remote progress monitoring, exercise library management, and secure caregiver messaging; and a patient/family mobile app featuring age-appropriate exercise videos, progress tracking, smartphone-enabled physical ability challenges, and gamified rewards to enhance compliance. Key capabilities include real-time data-driven insights with early intervention alerts, comprehensive documentation for remote therapeutic monitoring (RTM) billing and compliance, and customizable content integration allowing facilities to add hospital-approved materials. The solution addresses fragmentation in pediatric rehabilitation by consolidating PT, OT, and SLP needs in one integrated system, improving continuity of care and enabling therapists to adjust programs remotely rather than relying on generic external resources. YourSteps is widely adopted in pediatric hospitals, rehabilitation facilities, and therapy service providers across the United States. The platform received the 2024 APTA Pediatrics Practice Fair Innovation Award. The company operates as a B2B SaaS solution targeting rehab managers, therapists, and pediatric healthcare systems seeking to improve outcomes and operational efficiency.